Now showing items 1-3 of 3
| Abstract: | Ruthenium(III) complexes of the Schiff bases formed by the condensation of polymer bound aldehyde and the amines, such as 1,2-phenylenediamine (PS-opd), 2-aminophenol (PS-ap), and 2-aminobenzimidazole (PS-ab) have been prepared. The magnetic moment, EPR and electronic spectra suggest an octahedral structure for the complexes. The complexes of PS-opd, PS-ap, and PS-ab have been assigned the formula [PS-opdRuCl3(H2O)], [PS-apRuCl2(H2O)2], [PS-ab- RuCl3(H2O)2], respectively. These complexes catalyze oxidation of catechol using H2O2 selectively to o-benzoquinone. The catalytic activity of the complexes is in the order [PS-ab- RuCl3(H2O)2] . [PS-opdRuCl3(H2O)] [PS-apRuCl2(H2O)2]. Mechanism of the catalytic oxidation of catechol by ruthenium( III) complex is suggested to take place through the formation of a ruthenium(II) complex and its subsequent oxidation by H2O2 to the ruthenium(III) complex. |
| URI: | http://dyuthi.cusat.ac.in/xmlui/purl/1969 |
| Files | Size |
|---|---|
| K K M Yusuff,Characterization and cat....pdf | (162.6Kb) |
| Abstract: | Zeolite Y-encapsulated ruthenium(III) complexes of Schiff bases derived from 3-hydroxyquinoxaline-2-carboxaldehyde and 1,2- phenylenediamine, 2-aminophenol, or 2-aminobenzimidazole (RuYqpd, RuYqap and RuYqab, respectively) and the Schiff bases derived from salicylaldehyde and 1,2-phenylenediamine, 2-aminophenol, or 2-aminobenzimidazole (RuYsalpd, RuYsalap and RuYsalab, respectively) have been prepared and characterized. These complexes, except RuYqpd, catalyze catechol oxidation by H2O2 selectively to 1,2,4-trihydroxybenzene. RuYqpd is inactive. A comparative study of the initial rates and percentage conversion of the reaction was done in all cases. Turn over frequency of the catalysts was also calculated. The catalytic activity of the complexes is in the order RuYqap > RuYqab for quinoxaline-based complexes and RuYsalap > RuYsalpd > RuYsalab for salicylidene-based complexes. The reaction is believed to proceed through the formation of a Ru(V) species. |
| URI: | http://dyuthi.cusat.ac.in/purl/1652 |
| Files | Size |
|---|---|
| pearly j mol.pdf | (181.9Kb) |
| Abstract: | The title reaction was undertaken to establish the interaction between amantadine and molybdate at physiological pH. Identical FTIR spectra, TG-DTA curves and CHN data of the complexes formed from three solutions at pH 1.5, 7.4 and 8.0 indicate that the same complex was formed at all the three pHs. The FTIR spectrum shows shift in peaks corresponding to primary amino group of the drug due to coordination to molybdate. An octahedral geometry is assigned to the complex. The kinetics of the complexation has been studied at low concentrations of the reactants using UV-visible spectrophotometry. At pH 7.4, the initial rate varies linearly with [molybdate]. A plot of initial rate versus [drug] is linear passing through origin. These results indicate that the drug and molybdate react at pH 7.4 even at low concentrations. At pH 1.5, the rate increases linearly with increase in [drug] but decreases with [molybdate]. The effect of pH and ionic strength on the rate of the reaction has also been studied. A suitable mechanism has been proposed for the reaction. Reaction between the drug and molybdate even at low concentrations and the fact that the amino group of amantadine required to be free for its function as antiviral, is bound to molybdate in the complex suggests that simultaneous administration of the drug and molybdate supplements should be avoided. |
| URI: | http://dyuthi.cusat.ac.in/purl/2979 |
| Files | Size |
|---|---|
| Dyuthi-P00414.pdf | (143.3Kb) |
Now showing items 1-3 of 3
Dyuthi Digital Repository Copyright © 2007-2011 Cochin University of Science and Technology. Items in Dyuthi are protected by copyright, with all rights reserved, unless otherwise indicated.